Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
29.78
Dollar change
-0.06
Percentage change
-0.20
%
IndexRUT P/E19.59 EPS (ttm)1.52 Insider Own0.79% Shs Outstand174.58M Perf Week-1.13%
Market Cap5.18B Forward P/E21.79 EPS next Y1.37 Insider Trans2.46% Shs Float172.44M Perf Month-3.62%
Income272.67M PEG1.96 EPS next Q0.28 Inst Own97.54% Short Float2.85% Perf Quarter-12.23%
Sales4.43B P/S1.17 EPS this Y-19.96% Inst Trans3.09% Short Ratio3.62 Perf Half Y1.12%
Book/sh8.22 P/B3.62 EPS next Y15.39% ROA8.55% Short Interest4.92M Perf Year5.64%
Cash/sh1.26 P/C23.58 EPS next 5Y10.00% ROE19.62% 52W Range26.17 - 35.74 Perf YTD-11.61%
Dividend Est.- P/FCF30.30 EPS past 5Y- ROI10.59% 52W High-16.68% Beta1.31
Dividend TTM- Quick Ratio1.39 Sales past 5Y17.51% Gross Margin21.01% 52W Low13.79% ATR (14)0.76
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM74.47% Oper. Margin7.15% RSI (14)41.08 Volatility1.76% 2.85%
Employees5809 Debt/Eq0.82 Sales Y/Y TTM9.59% Profit Margin6.15% Recom1.11 Target Price39.45
Option/ShortYes / Yes LT Debt/Eq0.80 EPS Q/Q18.83% Payout0.00% Rel Volume0.60 Prev Close29.84
Sales Surprise4.03% EPS Surprise15.15% Sales Q/Q12.82% EarningsApr 23 BMO Avg Volume1.36M Price29.78
SMA20-1.01% SMA50-4.66% SMA200-6.83% Trades Volume813,734 Change-0.20%
Date Action Analyst Rating Change Price Target Change
Feb-27-23Resumed Jefferies Buy $38
Jul-19-21Upgrade Goldman Neutral → Buy $20 → $25
Jan-22-21Initiated Deutsche Bank Buy $22
Jan-11-21Initiated JP Morgan Overweight $21
Dec-15-20Initiated Goldman Neutral $18
Jun-24-20Initiated BofA/Merrill Buy $18
May-16-24 05:23PM
04:05PM
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
11:27AM Loading…
Apr-25-24 11:27AM
Apr-24-24 03:49AM
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
07:00AM
Apr-22-24 12:10PM
10:00AM Loading…
Apr-16-24 10:00AM
Apr-04-24 04:05PM
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
08:20AM
07:31AM
07:24AM
07:00AM
Feb-02-24 06:10AM
04:05PM Loading…
Jan-22-24 04:05PM
Jan-08-24 07:00AM
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
07:05PM
09:56AM
08:15AM
07:08AM
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bavaro MichaelChief Human Resources OfficerFeb 28 '24Sale31.731,98462,94443,428Mar 01 04:28 PM
KRAEMER HARRY M JANSEN JRDirectorFeb 26 '24Buy31.5535,0001,104,352269,528Feb 28 04:41 PM
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '24Option Exercise0.0011,0870705,876Feb 23 06:21 PM
SHAPIRO MICHAEL H.Chief Financial OfficerFeb 17 '24Option Exercise0.003,6520180,570Feb 21 09:55 PM
Bierbower Elizabeth DDirectorOct 30 '23Buy26.373,00079,11013,515Nov 01 05:09 PM
Pate R CarterDirectorAug 17 '23Buy34.321,46550,279106,112Aug 21 05:08 PM
Smyser CollinGC & Corporate SecretaryAug 14 '23Buy34.692,50086,7252,500Aug 15 05:24 PM
KRAEMER HARRY M JANSEN JRDirectorAug 11 '23Buy34.6355,0001,904,518234,528Aug 15 05:26 PM
Last Close
May 17 04:00PM ET
1.48
Dollar change
-0.01
Percentage change
-0.67
%
IndexRUT P/E- EPS (ttm)-1.35 Insider Own3.79% Shs Outstand105.51M Perf Week-3.90%
Market Cap159.07M Forward P/E- EPS next Y-0.19 Insider Trans0.10% Shs Float103.41M Perf Month-3.27%
Income-142.06M PEG- EPS next Q-0.12 Inst Own76.11% Short Float4.15% Perf Quarter0.68%
Sales526.84M P/S0.30 EPS this Y42.49% Inst Trans-7.95% Short Ratio5.98 Perf Half Y135.82%
Book/sh0.61 P/B2.43 EPS next Y52.00% ROA-34.71% Short Interest4.29M Perf Year-58.31%
Cash/sh0.32 P/C4.61 EPS next 5Y15.00% ROE-102.02% 52W Range0.55 - 3.78 Perf YTD43.69%
Dividend Est.- P/FCF- EPS past 5Y-17.83% ROI-66.66% 52W High-60.85% Beta2.06
Dividend TTM- Quick Ratio0.75 Sales past 5Y16.25% Gross Margin33.40% 52W Low171.51% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.50 EPS Y/Y TTM-24.83% Oper. Margin-19.43% RSI (14)43.36 Volatility6.32% 7.19%
Employees1700 Debt/Eq2.48 Sales Y/Y TTM-2.78% Profit Margin-26.97% Recom2.25 Target Price2.75
Option/ShortYes / Yes LT Debt/Eq2.25 EPS Q/Q-100.00% Payout- Rel Volume0.60 Prev Close1.49
Sales Surprise-1.73% EPS Surprise-18.09% Sales Q/Q9.75% EarningsMay 07 AMC Avg Volume717.70K Price1.48
SMA20-4.28% SMA50-10.19% SMA200-0.33% Trades Volume430,458 Change-0.67%
Date Action Analyst Rating Change Price Target Change
Mar-13-24Upgrade ROTH MKM Neutral → Buy $2 → $2.50
Nov-10-22Upgrade Craig Hallum Hold → Buy $4 → $6
Mar-02-22Reiterated UBS Neutral $10 → $6.50
Mar-02-22Reiterated Truist Hold $10 → $5
Mar-02-22Reiterated KeyBanc Capital Markets Overweight $22 → $16
Mar-02-22Reiterated BofA Securities Underperform $5.50 → $4.50
Mar-02-22Reiterated B. Riley Securities Neutral $9 → $6
Mar-02-22Downgrade ROTH Capital Buy → Neutral $10 → $6
Nov-10-21Downgrade UBS Buy → Neutral $32 → $15
Nov-10-21Downgrade Truist Buy → Hold $12
May-14-24 10:35AM
May-08-24 12:24PM
06:25AM
03:52AM
May-07-24 09:56PM
06:28PM Loading…
06:28PM
05:55PM
05:06PM
05:05PM
04:05PM
May-06-24 03:06AM
May-01-24 06:30AM
Apr-30-24 04:05PM
Apr-24-24 01:12PM
Apr-22-24 02:50AM
08:50AM Loading…
Apr-11-24 08:50AM
Mar-26-24 08:50AM
Mar-23-24 06:00AM
Mar-14-24 05:32PM
08:19AM
Mar-13-24 04:05PM
07:02AM
Mar-12-24 05:34PM
05:15PM
04:22PM
04:05PM
04:03PM
Feb-27-24 04:05PM
Jan-23-24 04:05PM
Jan-03-24 04:05PM
04:05PM Loading…
Dec-04-23 04:05PM
Nov-14-23 12:30PM
Nov-11-23 12:12PM
Nov-10-23 09:43AM
Nov-09-23 06:26PM
04:05PM
Nov-07-23 09:07AM
Nov-01-23 08:00AM
Oct-24-23 04:05PM
Sep-27-23 04:05PM
Sep-21-23 04:05PM
Sep-05-23 03:30PM
Aug-16-23 08:40AM
Aug-14-23 03:51PM
Aug-10-23 03:27PM
09:13AM
Aug-09-23 05:40PM
04:27PM
04:05PM
Aug-04-23 11:44AM
Aug-02-23 04:05PM
Jun-15-23 04:09PM
Jun-12-23 08:00AM
May-15-23 09:00AM
May-11-23 09:03AM
May-10-23 05:55PM
04:51PM
04:05PM
May-09-23 02:43PM
May-02-23 05:46PM
10:02AM
Apr-21-23 06:35PM
10:39AM
Apr-13-23 04:05PM
Apr-04-23 12:39PM
Mar-28-23 06:46AM
Mar-26-23 07:22AM
Mar-22-23 06:32AM
Mar-20-23 04:10AM
Mar-17-23 08:03AM
Mar-16-23 05:25PM
04:06PM
04:05PM
Mar-14-23 08:48AM
Mar-10-23 09:35AM
Mar-07-23 04:05PM
12:45PM
Feb-28-23 10:00AM
Feb-23-23 09:35AM
Feb-21-23 01:50PM
Feb-17-23 12:45PM
Feb-14-23 02:30PM
08:30AM
Feb-13-23 05:24PM
08:30AM
Feb-08-23 10:59PM
04:03PM
Feb-02-23 06:59AM
Jan-30-23 12:45PM
08:00AM
Jan-20-23 06:35PM
08:50AM
Jan-19-23 08:15AM
08:00AM
Jan-13-23 05:15PM
Jan-12-23 04:30PM
Jan-04-23 04:15PM
Dec-15-22 10:02AM
Dec-07-22 08:50AM
Nov-14-22 09:55AM
Purple Innovation, Inc. engages in the design and manufacture of comfort technology products. It offers mattresses, bed pillows, seat cushions, mattress protector, and bamboo sheets. The company was founded by Terry V. Pearce and Tony Marion Pearce in 1989 and is headquartered in Lehi, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ulrich George TurnerPrincipal Accounting OfficerMar 22 '24Buy1.524,0006,06116,874Mar 26 08:00 AM
DICAMILLO GARY TDirectorAug 28 '23Buy2.2210,00022,182158,478Aug 30 11:03 AM
McGarvey Casey KaleChief Legal OfficerJun 02 '23Buy2.8522,30063,553108,436Jun 06 04:10 PM
KERBY JEFFERY SCOTTChief of Owned RetailMay 26 '23Buy3.4516,35056,44539,427May 30 05:44 PM